Back
Intellia Therapeutics Vs. Xtant Medical Holdings Industry Stock Comparison
Sell
29
NTLA
Intellia Therapeutics
Last Price:
15.12
Seasonality Move:
12.78%
Buy
52
XTNT
Xtant Medical Holdings
Last Price:
0.45
Seasonality Move:
-9.65%
Sell
29
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $16.11. The Score for NTLA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Xtant Medical Holdings (XTNT)
is a Buy
Is Xtant Medical Holdings a Buy, Sell or Hold?
- The current Xtant Medical Holdings [XTNT] share price is $0.47. The Score for XTNT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- XTNT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $16.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.
XTNT Stock Price Chart
What is Xtant Medical Holdings's stock price today?
-
The Xtant Medical Holdings share price today is $0.47
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTNT is experiencing selling pressure, which indicates risk of future bearish movement.
NTLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.81 | Sell |
| Relative Strength Index (14 RSI): | 42.72 | Sell |
| Chaikin Money Flow: | -2062488 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.13 - 19.47) | Sell |
| Bollinger Bands (100): | (18.1 - 24.6) | Sell |
XTNT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 28.91 | Sell |
| Chaikin Money Flow: | -183568 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.52 - 0.58) | Sell |
| Bollinger Bands (100): | (0.56 - 0.7) | Sell |
NTLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.21 | Sell |
| 20-day SMA: | 16.97 | Sell |
| 50-day SMA: | 18.87 | Sell |
| 200-day SMA: | 23.46 | Sell |
| 8-day EMA: | 16.33 | Sell |
| 20-day EMA: | 16.84 | Sell |
| 50-day EMA: | 18.6 | Sell |
| 200-day EMA: | 23.49 | Sell |
XTNT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.52 | Sell |
| 20-day SMA: | 0.54 | Sell |
| 50-day SMA: | 0.59 | Sell |
| 200-day SMA: | 0.78 | Sell |
| 8-day EMA: | 0.52 | Sell |
| 20-day EMA: | 0.54 | Sell |
| 50-day EMA: | 0.58 | Sell |
| 200-day EMA: | 0.74 | Sell |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.17 per share.
Xtant Medical Holdings Earnings Growth & XTNT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.07 per share.
Intellia Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xtant Medical Holdings Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||